Q4 2016 13F Holders as of 31 Dec 2016
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
170,107,714
-
Total 13F shares
-
119,942,754
-
Share change
-
+3,774,182
-
Total reported value
-
$3,459,110,173
-
Put/Call ratio
-
112%
-
Price per share
-
$28.84
-
Number of holders
-
214
-
Value change
-
+$99,389,058
-
Number of buys
-
114
-
Number of sells
-
102
Institutional Holders of ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) as of Q4 2016
As of 31 Dec 2016,
ACADIA PHARMACEUTICALS INC - Common Stock, $0.0001 par value (ACAD) was held by
214 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
119,942,754 shares.
The largest 10 holders included
BAKER BROS. ADVISORS LP, FMR LLC, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, OppenheimerFunds, Inc., FRANKLIN RESOURCES INC, Capital World Investors, JANUS CAPITAL MANAGEMENT LLC, STATE STREET CORP, and WADDELL & REED FINANCIAL INC.
This page lists
214
institutional shareholders reporting positions in this security
for the Q4 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.